🇺🇸 FDA
Pipeline program

Controlled low central venous pressure (CLCVP) technology

CT20230104

Unknown other completed

Quick answer

Controlled low central venous pressure (CLCVP) technology for Acute Kidney Injury is a Unknown program (other) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Acute Kidney Injury
Phase
Unknown
Modality
other
Status
completed

Clinical trials